Median age(range), years | 51(32–71) |
---|---|
Pre-surgery SCC-Ag (ng/ml) | 2.49(0.31–71.75) |
FIGO stage | |
IB1 (%) | 28(30.4%) |
IB2 (%) | 10(10.9%) |
IIA1 (%) | 30(32.6%) |
IIA2 (%) | 24(26.1%) |
Tumor size > 4 cm (%) | 33(35.9%) |
Stromal invasion > 1/2 depth (%) | 71(77.2%) |
LVSI positive (%) | 54(58.7%) |
Lymph node metastasis (%) | 33(35.9%) |
Adjuvant treatment (%) | 45(48.9%) |